Gilead Sciences (GILD) EPS (Basic) (2009 - 2026)
Gilead Sciences posted quarterly EPS (Basic) of $1.63 for Q1 2026, up 53.77% year-on-year from $1.06 in Q1 2025, and down 7.39% on a QoQ basis from $1.76 in Q4 2025.
Gilead Sciences (GILD) has 18 years of EPS (Basic) data on file, last reported at $1.63 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 53.77% year-over-year to $1.63; the trailing twelve-month figure through Mar 2026 stood at $7.42 (up 55.56% YoY), and the FY2025 full-year result was $6.84, up 1700.0% from the prior year.
- EPS (Basic) for Q1 2026 stood at $1.63, down from $1.76 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.46 in Q3 2025 and bottomed at -$3.34 in Q1 2024.
- The 5-year median for EPS (Basic) is $1.29 (2024), against an average of $1.0.
- The widest annual swing landed in 2023, when EPS (Basic) jumped 3950.0%; it then tumbled 512.35% in 2024.
- A 5-year view of EPS (Basic) shows it stood at $1.31 in 2022, then declined by 12.21% to $1.15 in 2023, then rose by 23.48% to $1.42 in 2024, then climbed by 23.94% to $1.76 in 2025, then slipped by 7.39% to $1.63 in 2026.
- The last three EPS (Basic) figures came in at $1.63 (Q1 2026), $1.76 (Q4 2025), and $2.46 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 8.27 |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.17 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 0.39 |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -1.72 |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 3.37 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.63 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 0.48 |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.31 |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63 |
| Dec 31, 2025 | 1.76 |
| Sep 30, 2025 | 2.46 |
| Jun 30, 2025 | 1.57 |
| Mar 31, 2025 | 1.06 |
| Dec 31, 2024 | 1.42 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | 1.29 |
| Mar 31, 2024 | -3.34 |
| Dec 31, 2023 | 1.15 |
| Sep 30, 2023 | 1.75 |
| Jun 30, 2023 | 0.84 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 1.31 |
| Sep 30, 2022 | 1.43 |
| Jun 30, 2022 | 0.91 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.31 |
| Sep 30, 2021 | 2.06 |
| Jun 30, 2021 | 1.21 |
| Mar 31, 2021 | 1.38 |
| Dec 31, 2020 | 1.24 |
| Sep 30, 2020 | 0.29 |
| Jun 30, 2020 | -2.66 |
| Mar 31, 2020 | 1.23 |
| Dec 31, 2019 | 2.13 |
| Sep 30, 2019 | -0.92 |
| Jun 30, 2019 | 1.48 |
| Mar 31, 2019 | 1.55 |
| Dec 31, 2018 | 0.22 |
| Sep 30, 2018 | 1.62 |
| Jun 30, 2018 | 1.40 |
| Mar 31, 2018 | 1.18 |
| Dec 31, 2017 | -2.96 |
| Sep 30, 2017 | 2.08 |
| Jun 30, 2017 | 2.35 |
| Mar 31, 2017 | 2.07 |
| Dec 31, 2016 | 2.36 |
| Sep 30, 2016 | 2.52 |
| Jun 30, 2016 | 2.62 |
| Mar 31, 2016 | 2.58 |
| Dec 31, 2015 | 3.26 |
| Sep 30, 2015 | 3.14 |
| Jun 30, 2015 | 3.05 |
| Mar 31, 2015 | 2.91 |
| Dec 31, 2014 | 2.32 |
| Sep 30, 2014 | 1.80 |
| Jun 30, 2014 | 2.39 |
| Mar 31, 2014 | 1.45 |
| Dec 31, 2013 | 0.52 |
| Sep 30, 2013 | 0.51 |
| Jun 30, 2013 | 0.51 |
| Mar 31, 2013 | 0.47 |
| Dec 31, 2012 | 0.50 |
| Sep 30, 2012 | 0.45 |
| Jun 30, 2012 | 0.47 |
| Mar 31, 2012 | 0.29 |
| Dec 31, 2011 | 0.44 |
| Sep 30, 2011 | 0.48 |
| Jun 30, 2011 | 0.48 |
| Mar 31, 2011 | 0.41 |
| Dec 31, 2010 | 0.78 |
| Sep 30, 2010 | 0.85 |
| Jun 30, 2010 | 0.81 |
| Mar 31, 2010 | 0.95 |
| Dec 31, 2009 | 0.89 |
| Sep 30, 2009 | 0.75 |
| Jun 30, 2009 | 0.63 |
| Mar 31, 2009 | 0.65 |